RESEARCH Open Access Local prostate cancer radi p y D

Full list of author information is available at the end of the articlelished radiotherapy (RT) techniques for a curative treat-ment of localized prostate cancer [1-7]. The combination with hormonal therapy (HT) has been shown to be associated with improved overall survival for high risk patients after EBRT in several prospective randomized studies [8-12]. HT is frequently administered before brachytherapy for downsizing the prostate volume [13]. survival benefit for high risk patients in randomized trials addressing this question [9,10,14]. A difference was even found for a neoadjuvant HT comparing eight versus three months [14]. In daily practice, patients sometimes do not receive a well defined short-term neoadjuvant HT before present-ing in the radiotherapy department. In some cases, de-finitive curative treatment is only postponed. Patients sometimes receive HT until PSA levels rise after an ini-tial PSA nadir. These patients were in focus of this analysis. * Correspondence